Active Ingredient: BUPROPION HYDROCHLORIDE
Proprietary Name: BUPROPION HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB3
Application Number: A211020
Product Number: 001
Approval Date: Jan 28, 2019
Applicant Holder Full Name: GRAVITI PHARMACEUTICALS PRIVATE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information